M&A Deal Summary |
|
|---|---|
| Date | 2013-11-18 |
| Target | Cisbio Bioassays SAS |
| Sector | Life Science |
| Buyer(s) | Argos Wityu |
| Sellers(s) | IBA |
| Deal Type | Divestiture |
| Deal Value | 25M EUR |
SEARCH BY
| Category | Private Equity Firm |
|---|---|
| Founded | 1989 |
| PE ASSETS | 1.8B EUR |
| Size | Large |
| Type | Sector Agnostic |
Argos Soditic is a private equity firm that seeks majority or minority investments in small to medium sized companies headquartered throughout Europe. Argos Soditic will consider investments in public or private companies generating revenue of €20 to €600 million. The Firm's target investment size is €10 to €100 million. Funds are typically used to support management buyouts/buy-ins, divestitures, and growth capital needs. Argos Soditic is a generalist investor with interest in aerospace, manufacturing, distribution, business services, chemicals, marketing, industrial products, packaging, staffing, medical products, and healthcare services. Argos Soditic was formed in 1989 and is headquartered in Paris.
| DEAL STATS | # |
|---|---|
| Overall | 45 of 84 |
| Sector: Life Science M&A | 1 of 1 |
| Type: Divestiture M&A Deals | 12 of 15 |
| Country: France M&A | 24 of 43 |
| Year: 2013 M&A | 9 of 9 |
| Size (of disclosed) | 3 of 7 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2013-11-12 |
Aytos Soluciones Informáticas S.L.U.
Ecija, Spain Aytos Soluciones Informáticas S.L.U. develops and implements of Administration Resource Planning (ARP) software solutions and Electronic Administration for Spanish public entities. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2014-01-01 |
Implanta
Milan, Italy Implanta (Odos Service) offer a complete range of dental services. These services go from hygiene to implantology, with hospital class standards and the capability to handle, in addition to ordinary patients, those more fragile under long-term treatment at the hospital. Implanta (Odos Service) is based in Milan, Italy. |
Buy | - |
| Category | Company |
|---|---|
| Founded | 1986 |
| Sector | Medical Products |
| Employees | 1,943 |
| Revenue | 498M EUR (2024) |
IBA develops innovative solutions by sharing ideas and know-how with customers, partners and leading experts to bring new solutions for the diagnosis and treatment of cancer and for the benefits of patients. IBA was founded in 1986 and is based in Louvain-La-Neuve, Belgium.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 3 |
| Sector: Life Science M&A | 1 of 1 |
| Type: Divestiture M&A Deals | 1 of 2 |
| Country: France M&A | 1 of 1 |
| Year: 2013 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2012-04-01 |
IBA Molecular Imaging
Dulles, Vermont, United States IBA Molecular is a global developer, manufacturer and distributor of radiopharmaceutical products and supporting services used in molecular imaging. IBA Molecular has engineered a strong and unique product portfolio and pipeline of diagnostic and therapeutic tracers aimed at advancing the development of the global movement towards personalized medicine and making molecular imaging/therapy a major discipline in healthcare. The company also provides educational, technical and marketing support to medical specialists worldwide to help better respond to patient needs. |
Buy | €180M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2015-12-14 |
IBA Molecular Imaging
Dulles, Vermont, United States IBA Molecular is a global developer, manufacturer and distributor of radiopharmaceutical products and supporting services used in molecular imaging. IBA Molecular has engineered a strong and unique product portfolio and pipeline of diagnostic and therapeutic tracers aimed at advancing the development of the global movement towards personalized medicine and making molecular imaging/therapy a major discipline in healthcare. The company also provides educational, technical and marketing support to medical specialists worldwide to help better respond to patient needs. |
Sell | - |
